Steroid Response Following Dropless Cataract Surgery Using Subconjunctival Triamcinolone

References

• Grzybowski A. Recent developments in cataract surgery. Ann Transl Med. 2020;8(22):1540. doi:10.21037/atm-2020-rcs-16
   PubMed Web of Science ®Google Scholar
• Paganelli F, Cardillo JA, Melo LA Jr, Oliveira AG, Skaf M, Costa RA. A single intraoperative sub-Tenon’s capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology. 2004;111(11):2102–2108. doi:10.1016/j.ophtha.2004.04.026
   PubMed Web of Science ®Google Scholar
• Lindholm JM, Taipale C, Ylinen P, Tuuminen R. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmol. 2020;98(1):36–42. doi:10.1111/aos.14175
   PubMed Web of Science ®Google Scholar
• Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PW. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011;37(9):1589–1597. doi:10.1016/j.jcrs.2011.03.049
   PubMed Web of Science ®Google Scholar
• Reddy JK, Chaitanya V, Shah N, Guduru VP, Khan S, Kuttupalayam S. Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery. Int J Ophthalmol. 2019;12(5):774–778. doi:10.18240/ijo.2019.05.11
   PubMed Web of Science ®Google Scholar
• Kuriakose RK, Cho S, Nassiri S, Hwang FS. Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery. J Ophthalmol. 2022;2022:4857696. doi:10.1155/2022/4857696
   PubMed Web of Science ®Google Scholar
• Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31(1):67–73. doi:10.1097/icu.0000000000000625
   PubMed Web of Science ®Google Scholar
• Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2021;32(Suppl 1):S1–s12. doi:10.1097/icu.0000000000000708
   PubMedGoogle Scholar
• Hermann MM, Ustündag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30(4):385–390. doi:10.1007/s10792-010-9362-3
   PubMedGoogle Scholar
• An JA, Kasner O, Samek DA, Lévesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40(11):1857–1861. doi:10.1016/j.jcrs.2014.02.037
   PubMed Web of Science ®Google Scholar
• Kuley B, Storey PP, Pancholy M, et al. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone. Can J Ophthalmol. 2020;55(6):480–485. doi:10.1016/j.jcjo.2020.06.021
   PubMed Web of Science ®Google Scholar
• Rezkallah A, Mathis T, Abukhashabah A, et al. Long-term incidence and risk factors of ocular hypertension following dexamethasone-implant injections: the safodex-2 study. Retina. 2021;41(7):1438–1445. doi:10.1097/iae.0000000000003080
   PubMed Web of Science ®Google Scholar
• Rhee DJ, Peck RE, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90(8):999–1003. doi:10.1136/bjo.2006.090340
   PubMed Web of Science ®Google Scholar
• Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology. 2005;112(4):593–598. doi:10.1016/j.ophtha.2004.10.042
   PubMed Web of Science ®Google Scholar
• Merkoudis N, Wikberg Matsson A, Granstam E. Comparison of peroperative subconjunctival injection of methylprednisolone and standard postoperative steroid drops after uneventful cataract surgery. Acta Ophthalmol. 2014;92(7):623–628. doi:10.1111/aos.12358
   PubMed Web of Science ®Google Scholar
• Negi AK, Browning AC, Vernon SA. Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: randomized controlled trial. J Cataract Refract Surg. 2006;32(3):468–474. doi:10.1016/j.jcrs.2005.12.102
   PubMed Web of Science ®Google Scholar
• Choopong P, Taetrongchit N, Boonsopon S, et al. Efficacy of subtenon 20-mg triamcinolone injection versus 0.1% dexamethasone eye drops for controlling inflammation after phacoemulsification: a randomized controlled trial. Sci Rep. 2022;12(1):16471. doi:10.1038/s41598-022-20522-y
   PubMed Web of Science ®Google Scholar
• Paganelli F, Cardillo JA, Melo LA Jr, et al. A single intraoperative sub-tenon’s capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. Invest Ophthalmol Vis Sci. 2009;50(7):3041–3047. doi:10.1167/iovs.08-2920
   PubMed Web of Science ®Google Scholar
• Bojikian KD, Nobrega P, Roldan A, Forrest SL, Tsukikawa M, Chen PP. Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma. J Glaucoma. 2021;30(4):e159–e163. doi:10.1097/ijg.0000000000001785
   PubMed Web of Science ®Google Scholar
• Chang DF, Tan JJ, Tripodis Y. Risk factors for steroid response among cataract patients. J Cataract Refract Surg. 2011;37(4):675–681. doi:10.1016/j.jcrs.2010.10.051
   PubMed Web of Science ®Google Scholar
• Rajendrababu S, Pallamparthy S, Arunachalam A, et al. Incidence and risk factors for postoperative intraocular pressure response to topical prednisolone eye drops in patients undergoing phacoemulsification. Int Ophthalmol. 2021;41(12):3999–4007. doi:10.1007/s10792-021-01972-1
   PubMed Web of Science ®Google Scholar
• Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–720. doi:10.1001/archopht.120.6.714
   PubMedGoogle Scholar
• Probst LE, Hakim OJ, Nichols BD. Phacoemulsification with aspirated or retained Viscoat. J Cataract Refract Surg. 1994;20(2):145–149. doi:10.1016/s0886-3350(13)80154-x
   PubMed Web of Science ®Google Scholar
• Raghunathan VK, Morgan JT, Park SA, et al. Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix. Invest Ophthalmol Vis Sci. 2015;56(8):4447–4459. doi:10.1167/iovs.15-16739
   PubMed Web of Science ®Google Scholar
• Stewart RH, Smith JP, Rosenthal AL. Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate. Curr Eye Res. 1984;3(6):835–839. doi:10.3109/02713688409000796
   PubMed Web of Science ®Google Scholar
• Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26–34. doi:10.1016/j.jcrs.2008.09.024
   PubMed Web of Science ®Google Scholar
• Donnenfeld ED, Holland EJ, Solomon KD, et al. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. Am J Ophthalmol. 2011;152(4):609–617.e1. doi:10.1016/j.ajo.2011.03.018
   PubMed Web of Science ®Google Scholar
• Karasu B, Kesim E, Kaskal M, Celebi ARC. Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide. Cutan Ocul Toxicol. 2022;41(4):310–317. doi:10.1080/15569527.2022.2136193
   PubMed Web of Science ®Google Scholar
• Wielders LHP, Schouten J, Winkens B, et al. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2. J Cataract Refract Surg. 2018;44(7):836–847. doi:10.1016/j.jcrs.2018.05.015
   PubMed Web of Science ®Google Scholar
• Kalina RE. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol. 1969;81(6):788–790. doi:10.1001/archopht.1969.00990010790006
   PubMedGoogle Scholar
• Pham TQ, Wang JJ, Rochtchina E, Maloof A, Mitchell P. Systemic and ocular comorbidity of cataract surgical patients in a western Sydney public hospital. Clin Exp Ophthalmol. 2004;32(4):383–387. doi:10.1111/j.1442-9071.2004.00842.x
   PubMed Web of Science ®Google Scholar
• Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina. 2008;28(4):573–580. doi:10.1097/IAE.0b013e31816079e8
   PubMed Web of Science ®Google Scholar
• Mueller AJ, Jian G, Banker AS, Rahhal FM, Capparelli E, Freeman WR. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am J Ophthalmol. 1998;125(2):158–163. doi:10.1016/s0002-9394(99)80085-3
   PubMed Web of Science ®Google Scholar
• Herschler J. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol. 1976;82(1):90–93. doi:10.1016/0002-9394(76)90669-3
   PubMed Web of Science ®Google Scholar
• Akduman L, Kolker AE, Black DL, Del Priore LV, Kaplan HJ. Treatment of persistent glaucoma secondary to periocular corticosteroids. Am J Ophthalmol. 1996;122(2):275–277. doi:10.1016/s0002-9394(14)72027-6
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Zhang Y, et al. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study. Retina. 2012;32(9):1838–1843. doi:10.1097/IAE.0b013e31824fd384
   PubMed Web of Science ®Google Scholar
• Becker B, Mills DW. CORTICOSTEROIDS AND INTRAOCULAR PRESSURE. Arch Ophthalmol. 1963;70:500–507. doi:10.1001/archopht.1963.00960050502012
   PubMed Web of Science ®Google Scholar
• Malclès A, Dot C, Voirin N, et al. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): the SAFODEX study. Incidence and Risk Factors of Ocular Hypertension. Retina. 2017;37(7):1352–1359. doi:10.1097/iae.0000000000001369
   PubMed Web of Science ®Google Scholar
• Jackson KJ, Akrobetu D, Guduru A, Herndon LW. Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma. J Glaucoma. 2022;31(8):694–699. doi:10.1097/ijg.0000000000002037
   PubMed Web of Science ®Google Scholar
• Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266(3):369–374.
   PubMed Web of Science ®Google Scholar
• Friedman DS, Jampel HD, Muñoz B, West SK. The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study. Arch Ophthalmol. 2006;124(11):1625–1630. doi:10.1001/archopht.124.11.1625
   PubMedGoogle Scholar
• Rodriguez J, Sanchez R, Munoz B, et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology. 2002;109(4):737–743. doi:10.1016/s0161-6420(01)01008-9
   PubMed Web of Science ®Google Scholar